3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
1 min read
Webinar: Developing and Marketing IVDs and CDx in Europe: Challenges and Lessons Learned. Brought to you by SFL, a Veristat Company
7th November 2023, 16.00 to 17.00 CET
Please join our colleagues from SFL, a Veristat company, for an informative webinar that will provide you with insights into the regulatory framework and challenges on the development and marketing of in vitro diagnostics (IVDs) and companion diagnostics (CDx) in Europe, covering regulatory strategy, critical timelines, and interactions with stakeholders. The speakers will share their lessons learned on the basis of recent case studies and will present the latest policy and regulatory framework for IVDs and CDx along with an update on recent digital health initiatives in Europe. Participants will get the opportunity to ask questions during the Q&A. .
Speakers:
Sabrina Urwyler, Senior Manager Regulatory Affairs at SFL, a Veristat company.
Nathalie Schober-Ladani, Senior Director Head Public Affairs and Regulatory Intelligence at SFL, a Veristat company.
Daniel Clarke, Senior Manager Regulatory Affairs & Quality Assurance at SFL, a Veristat company.
Samuel Gavillet, Associate Director Public Affairs and Regulatory Intelligence at SFL, a Veristat company.
